MARKET

AKBLF

AKBLF

Alk-Abello A/S
OTCPK
36.10
NaN%
Closed 09:30 02/12 EST
OPEN
--
PREV CLOSE
36.10
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
36.10
52 WEEK LOW
33.05
MARKET CAP
7.27B
P/E (TTM)
46.09
1D
5D
1M
3M
1Y
5Y
1D
ALK receives positive recommendation for EURneffy® 1 mg: A needle-free anaphylaxis treatment for children
Barchart · 01/29 09:15
ALK to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
Barchart · 01/08 10:17
ALK – Financial calendar for the 2026 financial year
Barchart · 12/22/2025 09:13
Major shareholder announcement
Barchart · 12/19/2025 15:47
ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America
Barchart · 12/01/2025 08:35
ALK-Abelló Reports Strong Q3 Growth and Upgrades Outlook
TipRanks · 11/14/2025 04:07
ALK-abello A/S Earnings Call Highlights Growth and Challenges
TipRanks · 11/14/2025 00:15
ALK-Abelló A/S reports Q3 results
Seeking Alpha · 11/13/2025 15:41
More
About AKBLF
ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product offering comprises products for the management of anaphylaxis. Its allergy diagnostics product offering comprises allergen extracts for allergy testing, such as skin-prick tests. The Company operates worldwide through subsidiaries, production units and distributors in such countries as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States and China.

Webull offers ALK-Abello A/S stock information, including OTCPK: AKBLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKBLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKBLF stock methods without spending real money on the virtual paper trading platform.